Amgen Inc. sell Rothschild & Co Redburn
Start price
18.02.26
/
50%
€314.70
Target price
18.02.27
€168.84
Performance (%)
14.86%
Price
14.08.26
€358.95
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 14.86%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 18.02.27. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.999% | 0.999% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Rothschild___Co_Redb for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Rothschild & Co Redburn from $180.00 to $200.00. They now have a "sell" rating on the stock.
Ratings data for AMGN provided by MarketBeat

